Results 111 to 120 of about 52,129 (204)

Mouse Huntington’s Disease Homolog mRNA Levels: Variation and Allele Effects [PDF]

, 2003
KAREN T. DIXON, Jamie A. Cearley, Jesse M. Hunter, Peter J. Detloff   +3 more
openalex   +1 more source

Automatic selection model to identify neurodegenerative diseases

Digital Health
Objective This study evaluates machine learning algorithms’ effectiveness in classifying Parkinson’s disease and Huntington’s disease based on biomarker data obtained non-invasively from patients and healthy controls.
Eddy Sánchez-DelaCruz, Cecilia-Irene Loeza-Mejía, César Primero-Huerta, Mirta Fuentes-Ramos   +3 more
doaj   +1 more source

Pleomorphic Invasive Ductal Carcinoma of the Breast in a Patient with Huntington’s Disease

Case Reports in Pathology, 2014
A pleomorphic invasive ductal carcinoma developed in a patient with Huntington’s disease. The tumour showed marked nuclear pleomorphism and contained large number of bizarre tumour giant cells and abundant abnormal mitoses.
Sami Shousha
doaj   +1 more source

Huntington’s disease genetics [PDF]

, 2004
Richard H. Myers
openalex   +1 more source

The paradigm of Huntington’s disease: Therapeutic opportunities in neurodegeneration [PDF]

, 2004
Julie Leegwater‐Kim, J. Jang‐Ho
openalex   +1 more source

Huntington’s Disease Patients Show Impaired Perception of Disgust in the Gustatory and Olfactory Modalities [PDF]

, 2005
Ian Mitchell, H. Heims, E. A. Neville, Hugh Rickards   +3 more
openalex   +1 more source

Structural brain correlates of dementia in Huntington’s disease

NeuroImage: Clinical, 2020
Background: Huntington’s disease (HD) is a fatal genetic neurodegenerative disorder with no effective treatment currently available. Progressive basal ganglia and whole-brain atrophy and concurrent cognitive deterioration are prototypical aspects of HD ...
Saul Martinez-Horta, Frederic Sampedro, Andrea Horta-Barba, Jesús Perez-Perez, Javier Pagonabarraga, Beatriz Gomez-Anson, Jaime Kulisevsky   +6 more
doaj  

A Protein Interaction Network Links GIT1, an Enhancer of Huntingtin Aggregation, to Huntington’s Disease [PDF]

, 2005
Heike Goehler, Maciej Łałowski, Ulrich Stelzl, Stephanie Waelter, Martin Stroedicke, Uwe Worm, Anja Droege, Katrin S. Lindenberg, Maria Knoblich, Christian Haenig, Martin Herbst, Jaana Suopanki, Eberhard Scherzinger, Claudia Abraham, Bianca Bauer, Renate Hasenbank, Anja Fritzsche, Andreas H. Ludewig, K. Buessow, Sarah H Coleman, Claire‐Anne Gutekunst, G. Bernhard Landwehrmeyer, Hans Lehrach, Erich E. Wanker   +23 more
openalex   +1 more source

Singleton births after routine preimplantation genetic diagnosis using exclusion testing (D4S43 and D4S126) for Huntington’s disease [PDF]

, 2006
Melinda J. Jasper, Dong Hu, Jan Liebelt, Deborah Sherrin, Robert H. Watson, Kelton Tremellen, Nicole D. Hussey   +6 more
openalex   +1 more source

Elevated plasma and CSF neurofilament light chain concentrations are stabilized in response to mutant huntingtin lowering in the brains of Huntington’s disease mice

Translational Neurodegeneration
Background Therapeutic approaches aimed at lowering toxic mutant huntingtin (mHTT) levels in the brain can reverse disease phenotypes in animal models of Huntington's disease (HD) and are currently being evaluated in clinical trials.
Nicholas S. Caron, Lauren M. Byrne, Fanny L. Lemarié, Jeffrey N. Bone, Amirah E.-E. Aly, Seunghyun Ko, Christine Anderson, Lorenzo L. Casal, Austin M. Hill, David J. Hawellek, Peter McColgan, Edward J. Wild, Blair R. Leavitt, Michael R. Hayden   +13 more
doaj   +1 more source